By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Strategic Partners A/S

Strategic Partners A/S (OZYMF)

OTC Market Data in USD, Fundamentals in DKK
$90.00
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$3.75M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.09 - $90.00
52 Week Range

OZYMF Stock Price Chart

Explore Strategic Partners A/S interactive price chart. Choose custom timeframes to analyze OZYMF price movements and trends.

OZYMF Company Profile

Discover essential business fundamentals and corporate details for Strategic Partners A/S (OZYMF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

16 Jul 2019

Employees

1.00

CEO

Jakob Færch Bendtsen

Description

Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. The company was founded in 2009 and is based in Herlev, Denmark.

OZYMF Financial Timeline

Browse a chronological timeline of Strategic Partners A/S corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 21 Nov 2025

Earnings released on 22 May 2025

EPS came in at -$0.00 .

Earnings released on 18 Nov 2024

Earnings released on 14 May 2024

EPS came in at -$0.38 .

Stock split effective on 6 Dec 2023

Shares were split 1 : 1000 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 29 Jun 2023

EPS came in at -$0.36 .

Earnings released on 30 Dec 2022

EPS came in at -$1.04 surpassing the estimated -$593.91 by +99.83%.

Earnings released on 26 Sept 2022

EPS came in at -$2.35 surpassing the estimated -$692.26 by +99.66%.

Earnings released on 7 Jun 2022

EPS came in at -$4.66 surpassing the estimated -$855.88 by +99.46%, while revenue for the quarter reached $23.04M , beating expectations by +330.73%.

Earnings released on 31 Aug 2021

EPS came in at -$13.29 falling short of the estimated -$5.28 by -151.66%, while revenue for the quarter reached $13.15M .

Earnings released on 2 Mar 2021

EPS came in at -$12.44 surpassing the estimated -$2.54K by +99.51%.

OZYMF Stock Performance

Access detailed OZYMF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run